Adapalene
File:Adapalene.svg | |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Very low |
Excretion | Biliary |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C28H28O3 |
Molar mass | 412.52 g/mol |
Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.[1] It is currently marketed by Galderma under the trade names Differin® in some countries, and Adaferin® in India.
Indications
Adapalene is indicated for the topical treatment of acne vulgaris.
Adapalene has been shown to enhance the efficacity of topical clindamycin. Application of Adapalene gel to the skin 2-5 minutes before application of clindamycin enhances the overall efficacity of the treatment as compared to clindamycin alone
History
Adapalene was approved in 1996 by the U.S. Food and Drug Administration for use in the treatment of acne.
Dosage
Adapalene is applied once daily, after washing and before retiring. In some circumstances, when a patient complains of skin irritation, this may be decreased to once every other day until the irritation ceases.
Available Forms
Differin is available in two forms, 0.1% adapalene and now the newer 0.3% adapalene (as of July 07)
Pharmacology
Pharmacodynamics
Adapalene in small concentrations is a moderator of cellular differentiation, keratinization, and inflammatory processes. The exact mode of action of adapalene is unknown.
Pharmacokinetics
Adapalene is applied topically to the skin, and its absorption into the blood through this medium is very low. Only trace amounts of adapalene have been found in the plasma of chronically treated patients.
External links
References
- ↑ Rolewski S (2003). "Clinical review: topical retinoids". Dermatol Nurs. 15 (5): 447–50, 459–65. PMID 14619325.
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Dermatological preparations
- Retinoids
- Carboxylic acids
- Aromatic compounds